Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Tamar Freud is active.

Publication


Featured researches published by Tamar Freud.


Journal of the American Board of Family Medicine | 2009

Effectiveness of Vitamin B12 in Treating Recurrent Aphthous Stomatitis: A Randomized, Double-Blind, Placebo-Controlled Trial

Ilia Volkov; Inna Rudoy; Tamar Freud; Gabriel Sardal; Sody Abby Naimer; Roni Peleg; Yan Press

Background: The frequency of recurrent aphthous stomatitis (RAS), the most common oral mucosa lesions seen in primary care, is up to 25% in the general population. However, there has been no optimal therapeutic approach. Our objective was to confirm our previous clinical observation of the beneficial treatment of RAS with vitamin B12. Methods: A randomized, double-blind, placebo-controlled trial was done using primary care patients. A sublingual a dose of 1000 mcg of vitamin B12 was used in patients in the intervention group for 6 months. Results: In total, 58 patients suffering from RAS participated in the study: 31 were included in the intervention group and 27 were included in control group. All parameters of RAS among patients in the intervention group were recorded and compared with the control group. The duration of outbreaks, the number of ulcers, and the level of pain were reduced significantly (P < .05) at 5 and 6 months of treatment with vitamin B12, regardless of initial vitamin B12 levels in the blood. During the last month of treatment a significant number of participants in the intervention group reached “no aphthous ulcers status” (74.1% vs 32.0%; P < .01). Conclusion: Vitamin B12 treatment, which is simple, inexpensive, and low-risk, seems to be effective for patients suffering from RAS, regardless of the serum vitamin B12 level.


British Journal of Dermatology | 2015

Hidradenitis suppurativa and metabolic syndrome: a comparative cross-sectional study of 3207 patients

Guy Shalom; Tamar Freud; Ilana Harman-Boehm; I. Polishchuk; Arnon D. Cohen

Hidradenitis suppurativa (HS) is a chronic relapsing inflammatory skin disease.


Journal of Hypertension | 2016

Orthostatic hypotension and drug therapy in patients at an outpatient comprehensive geriatric assessment unit.

Yan Press; Boris Punchik; Tamar Freud

Objective: To assess the rate of orthostatic hypotension and factors associated with it among elderly patients who underwent a comprehensive, ambulatory geriatric assessment. Methods: The study included patients 65 years and older who were assessed in the outpatient comprehensive geriatric assessment unit. Data were collected from the computerized medical record including sociodemographic data, lifestyle, falls, blood pressure, BMI, functional and cognitive status, medications, and comorbidity. Results: The study population consisted of 571 patients who underwent assessment over a nine-year period. The mean age was 83.7 ± 6.1, 35.9% were men, and 183 (32.1%) were diagnosed with orthostatic hypotension. Multiple drugs, in general, and multiple drugs with the potential to cause orthostatic hypotension in particular increased the risk for orthostatic hypotension after adjustment for age, sex, chronic comorbidity, and supine systolic blood pressure ≥150 mmHg [odds ratio (OR) = 1.09, 95% confidence interval (CI): 1.03–1.14 and OR = 1.22, 95% CI: 1.08–1.37, respectively]. In addition, &agr;-blockers and calcium channel blockers increased the risk for orthostatic hypotension after similar adjustments (OR = 1.82, 95% CI: 1.01–3.16 and OR = 1.66, 95% CI: 1.11–2.48, respectively). Similarly, two additional drug types increased the risk for orthostatic hypotension: selective serotonin reuptake inhibitors (OR = 2.09, 95% CI: 1.33–3.19) and tricyclic antidepressants (OR = 4.36, 95% CI: 1.85–10.06). There were no specific associations between age, cognitive and functional state, morbidity (as measured by the Charlson Comorbidity Index), and specific diseases, and orthostatic hypotension. Conclusion: The results of the present study reinforce evidence of an association between drug therapy and orthostatic hypotension.


Pain Medicine | 2009

Opioid Use in an Israeli Health Maintenance Organization: 2000–2006

Pesach Shvartzman; Tamar Freud; Yoram Singer; Silviu Brill; Michael Sherf; Erez Battat; Daniel A. Vardy

OBJECTIVE The objective of this study was to assess opioid use during 7 years (2000-2006) among Clalit Health Services (CHS) members. DESIGN Purchasing data of opioids authorized for use in Israel were obtained from the computerized databases of CHS. Patient demographics and cancer morbidity were also extracted. The data were analyzed by converting the purchased opioids to oral morphine equivalents (OMEs). SETTING CHS is the largest health maintenance organization in Israel (3,774,600) and insures almost 54% of the Israeli population. PATIENTS All CHS members who purchased an opioid at least once during the 7-year study period (2000-2006). INTERVENTION There were no interventions in this study. OUTCOME MEASURES The outcome measures of this study were total OME purchased per year, OME (mg) per capita/per year, and OME (mg) daily dose. RESULTS There were 119,562 patients who purchased an opioid at least once (3.2% of CHS population). Of them, 57.4% were women, 69.0% aged 65 years and above (average age 56.05 years +/- 26.7), 7.7% purchased opioids for more than 12 months, and 81.3% purchased opioids for only 1-4 months. A 96% increase in total OME purchased was found between 2000 and 2006 (from 56.4 kg to 110.6 kg). The annual OME purchased per capita increased from 15.7 mg in the year 2000 to 29.3 mg in 2006. The total number of patients who received at least one opioid prescription increased by 60%, while the growth in total number of CHS members was smaller (4.8%). CONCLUSIONS There is a growing use of opioids at CHS during the 7-year period, a potential indicator of the progress made in improving accessibility and availability of opioids in our health care organization in Israel.


Dermatology Research and Practice | 2013

Psoriatic Arthritis and Diabetes: A Population-Based Cross-Sectional Study

Jacob Dreiher; Tamar Freud; Arnon D. Cohen

Background. Diabetes has been associated with psoriasis, but little is known about the association between psoriatic arthritis and diabetes. Methods. Patients diagnosed with psoriatic arthritis by a rheumatologist were compared to age- and sex-matched patients without psoriatic arthritis regarding the prevalence of diabetes in a population-based cross-sectional study using logistic multivariate models. The study was performed utilizing the medical database of Clalit, the largest healthcare provider organization in Israel. Results. The study included 549 patients with psoriatic arthritis ≥21 years and 1,098 patients without psoriatic arthritis. The prevalence of diabetes in patients with psoriatic arthritis was increased as compared to the prevalence in patients without psoriatic arthritis (15.3% versus 10.7%, P value = 0.008). The difference was prominent among females (18.7% versus 10.3%, P < 0.001) but not among males (11.2% in patients with and without psoriatic arthritis, P = 1.000). In a multivariate analysis, psoriatic arthritis was associated with diabetes among females (OR = 1.60, 95% CI: 1.02–2.52, P = 0.040) but not among males (OR = 0.71, 95% CI: 0.42–1.22, P = 0.213). Conclusion. Our study suggests a possible association between psoriatic arthritis and diabetes in women. Women with psoriatic arthritis might be candidates for diabetes screening.


Journal of The American Academy of Dermatology | 2017

Biologic drug survival in Israeli psoriasis patients

Guy Shalom; Arnon D. Cohen; Michael Ziv; Cohen Barak Eran; Ilan Feldhamer; Tamar Freud; Eitan Berman; Shirley Oren; Emmilia Hodak; Lev Pavlovsky

Background Drug survival is defined as the time period of treatment with a certain drug until its cessation. The role of previous exposure to traditional systemic treatments in biologic survival is still unknown. Objective To investigate the drug survival rates of biologic treatments in patients with psoriasis and to identify predictor factors. Methods Survival analysis was performed on patients with severe psoriasis who received adalimumab, infliximab, etanercept, and ustekinumab for treatment of psoriasis, drawn from the Clalit Health Services database. Multivariate analysis was performed adjusting for demographic variables; metabolic syndrome and its components; psoriatic arthritis; biologic naivety; coadministration of methotrexate, acitretin, or cyclosporine; and previous standard systemic treatment exposure. Results Among 907 patients treated with 1575 biologic treatments, ustekinumab had a significantly higher survival rate than tumor necrosis factor inhibitors. Biologic naivety and concomitant methotrexate intake were positive predictors for drug survival, whereas the female sex and the duration of previous systemic treatments were negative predictors. Limitations Data regarding disease severity or duration could not be drawn from the Clalit Health Services database. Conclusion Ustekinumab had better retention rates in comparison with other investigated biologics in patients with severe psoriasis, most of whom used it as a third line therapy.


Medicine | 2015

Orthostatic Hypotension and Mortality in Elderly Frail Patients A Retrospective Cross-Sectional Study

Tamar Freud; Boris Punchik; Yan Press

AbstractOrthostatic hypotension (OH) is a common problem in the elderly age group, and some studies have reported an association between OH and increased mortality. We evaluated possible associations between OH and mortality in a retrospective study of frail elderly patients who came for a comprehensive geriatric assessment.The study included all patients ≥65 years who were assessed in the outpatient Comprehensive Geriatric Assessment Unit. Data were collected from the computerized medical record, including blood pressure, sociodemographic data, lifestyle, falls, pulse rate, body mass index, functional and cognitive status, and comorbidity. Data on mortlaity were also collected.The study population consisted of 571 patients who underwent assessment over a 9-year study period. The mean age was 83.7 ± 6.1, 35.9% were males, and 183 (32.1%) were diagnosed with OH. Systolic OH (OHS) was more common than diastolic OH (25.2% vs 15.6%). In univariate analyses, OHS was associated with increased overall mortality. Over the follow-up period, 30.2% of the OHS patients died compared with 22.3% (P = 0.037), but in the Cox models there was no statistically significant associations between OHS and overall mortality. In contrast, age, burden of comorbidity, a low high-density lipoprotein level, and low creatinine clearance were independent predictors of increased overall mortality.In a population of frail elderly patients with a high burden of comorbidity, OH was not an independent risk factor for overall mortality.


Journal of Alternative and Complementary Medicine | 2016

Aromatherapy for the Treatment of Patients with Behavioral and Psychological Symptoms of Dementia: A Descriptive Analysis of RCTs

Olga Press-Sandler; Tamar Freud; Ilya Volkov; Roni Peleg; Yan Press

BACKGROUND Behavioral and psychological symptoms of dementia (BPSD) are a common problem among patients with dementia. This problem is usually treated by drugs, but they have limited efficacy and often cause adverse effects. Aromatherapy is a nonpharmacologic treatment that is simple to use and devoid of significant adverse effects. OBJECTIVES To review the literature on the effectiveness of aromatherapy treatment in patients with BPSD. DESIGN A descriptive analysis of randomized clinical trials (RCTs) published in the English-language literature and cited in PubMed. RESULTS Eleven articles on RCTs were found, of which 1 had fewer than 10 participants, 2 were mistakenly presented as RCTs, and another did not report treatment for BPSD. In all, 7 articles with 417 participants total (range, 15-114) were reviewed. The mean age in all studies was greater than 69 years (range, 69-85 years), and the percentage of women was 55% (range, 50%-57%). The intervention period ranged from 10 days to 12 weeks. Two studies used Melissa oil and 5 others used lavender oil. The studies described different methods of administration for the oils, including spraying and rubbing over various body organs. The duration of treatment differed among the studies. In 3 studies the investigators concluded that the treatment was not effective and in 3 that it was effective; in 1 study no clear conclusion could be drawn. CONCLUSIONS The difference between positive and negative studies was not explained by differences in the study population, the type of oil, or the duration of treatment. The significant difference apparently stems from the method of administration. When the oil was applied close to the olfactory system the outcome was positive. A study should be designed to assess the effect of the site of application of aromatherapy.


Dementia and Geriatric Cognitive Disorders | 2012

A Retrospective Analysis of the Sentence Writing Component of the Mini Mental State Examination: Cognitive and Affective Aspects

Yan Press; Natalia Velikiy; Alex Berzak; Howard Tandeter; Roni Peleg; Tamar Freud; Boris Punchik; Tzvi Dwolatzky

Background: One of the components of the Mini Mental State Examination (MMSE) is the request to write a sentence. We investigated the relationship between the characteristics of the written sentence of the MMSE and the cognitive and affective status of elderly patients. Methods: The characteristics of the sentence were compared to the total MMSE score, sociodemographic characteristics, tests evaluating cognition and affective status, and diagnoses. Results: The number of words was significantly associated with the degree of cognitive impairment, whereas the emotional polarity of sentences and concerns about health were associated with depression. Conclusions: Characteristics of the MMSE sentence may provide important additional information regarding both cognition and affect when assessing older people.


Journal of Alternative and Complementary Medicine | 2009

Reasons for referrals of children and adolescents to alternative medicine in Southern Israel.

Carmit Erez; Haim Reuveni; Tamar Freud; Roni Peleg

OBJECTIVES The use of complementary and alternative medicine (CAM) has increased over recent years. Little is known about the use of CAM by children and adolescents. The study objectives were to characterize reasons for referrals and types of therapy for children and adolescents who turned to a CAM clinic. DESIGN An observational study with prospective collection of data through interviews with the parents conducted by the clinic triage physician using questionnaires. SUBJECTS Parents of children and adolescents who came for treatment to a CAM clinic. INTERVENTION None. OUTCOME MEASURES The medical reasons for using CAM. RESULTS The parents of 86 (55%) of the children who came for CAM in the study period, November 2005 to June 2006, participated in the study (54 males, 62.8%). The mean patient age was 6.75 years (median, 4.79). The most common reasons for CAM were immunological and allergy problems (30%), infectious diseases (21.4%), and attention deficit and concentration disorders (14.6%). The most common treatment modalities for children and adolescents were homeopathy (33.7%), reflexology (29.7%), and acupuncture (18.8%). Most of the immunological problems (58.1%) and the infectious diseases (66.7%) were referred for homeopathy, and most of the attention deficit and concentration disorders (66.7%) were treated by reflexology. Nonmedical reasons for CAM included disappointment with the results of conventional treatment; the desire for effective, innocuous, supplemental therapy; and previous experience among parents, friends, and family members. CONCLUSIONS Demand for CAM therapy for children is driven by universal factors. CAM can be an adjuvant therapy for children with common chronic pediatric problems.

Collaboration


Dive into the Tamar Freud's collaboration.

Top Co-Authors

Avatar

Yan Press

Ben-Gurion University of the Negev

View shared research outputs
Top Co-Authors

Avatar

Arnon D. Cohen

Ben-Gurion University of the Negev

View shared research outputs
Top Co-Authors

Avatar

Boris Punchik

Ben-Gurion University of the Negev

View shared research outputs
Top Co-Authors

Avatar

Roni Peleg

Ben-Gurion University of the Negev

View shared research outputs
Top Co-Authors

Avatar

Guy Shalom

Ben-Gurion University of the Negev

View shared research outputs
Top Co-Authors

Avatar

Jacob Dreiher

Ben-Gurion University of the Negev

View shared research outputs
Top Co-Authors

Avatar

Daniel A. Vardy

Ben-Gurion University of the Negev

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Amir Horev

Ben-Gurion University of the Negev

View shared research outputs
Top Co-Authors

Avatar

Ella Kagan

Ben-Gurion University of the Negev

View shared research outputs
Researchain Logo
Decentralizing Knowledge